These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 37954981)
1. The emerging field of opportunities for single-cell DNA methylation studies in hematology and beyond. Albinati L; Bianchi A; Beekman R Front Mol Biosci; 2023; 10():1286716. PubMed ID: 37954981 [No Abstract] [Full Text] [Related]
2. DNA methylation in normal and malignant hematopoiesis. Celik H; Kramer A; Challen GA Int J Hematol; 2016 Jun; 103(6):617-26. PubMed ID: 26943352 [TBL] [Abstract][Full Text] [Related]
3. Single-cell technologies and analyses in hematopoiesis and hematological malignancies. Campillo-Marcos I; Alvarez-Errico D; Alandes RA; Mereu E; Esteller M Exp Hematol; 2021 Jun; 98():1-13. PubMed ID: 33979683 [TBL] [Abstract][Full Text] [Related]
4. Impact of DNA methylation programming on normal and pre-leukemic hematopoiesis. Langstein J; Milsom MD; Lipka DB Semin Cancer Biol; 2018 Aug; 51():89-100. PubMed ID: 28964938 [TBL] [Abstract][Full Text] [Related]
5. Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer. Marzese DM; Hoon DS Expert Rev Mol Diagn; 2015 May; 15(5):647-64. PubMed ID: 25797072 [TBL] [Abstract][Full Text] [Related]
6. Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders. Găman AM Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372964 [TBL] [Abstract][Full Text] [Related]
7. DNA methylation and epigenomics: new technologies and emerging concepts. Chatterjee A; Eccles MR Genome Biol; 2015 May; 16(1):103. PubMed ID: 25990550 [TBL] [Abstract][Full Text] [Related]
9. Tumor purity and differential methylation in cancer epigenomics. Wang F; Zhang N; Wang J; Wu H; Zheng X Brief Funct Genomics; 2016 Nov; 15(6):408-419. PubMed ID: 27199459 [TBL] [Abstract][Full Text] [Related]
10. Functional annotation of genomic variation: DNA methylation episignatures in neurodevelopmental Mendelian disorders. Sadikovic B; Levy MA; Aref-Eshghi E Hum Mol Genet; 2020 Sep; 29(R1):R27-R32. PubMed ID: 32644126 [TBL] [Abstract][Full Text] [Related]
11. Epigenomics in stress tolerance of plants under the climate change. Kumar M; Rani K Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468 [TBL] [Abstract][Full Text] [Related]
12. Crossing Bacterial Genomic Features and Methylation Patterns with MeStudio: An Epigenomic Analysis Tool. Riccardi C; Passeri I; Cangioli L; Fagorzi C; Fondi M; Mengoni A Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613603 [TBL] [Abstract][Full Text] [Related]
13. Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies. Zuo F; Yu J; He X Front Oncol; 2022; 12():931393. PubMed ID: 35912231 [TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications. Yang X; Wong MPM; Ng RK Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527484 [TBL] [Abstract][Full Text] [Related]
15. TET2: A cornerstone in normal and malignant hematopoiesis. Kunimoto H; Nakajima H Cancer Sci; 2021 Jan; 112(1):31-40. PubMed ID: 33048426 [TBL] [Abstract][Full Text] [Related]
16. Challenges and Opportunities in Social Epigenomics and Cancer. Banaudha K; Kumar V; Verma M Methods Mol Biol; 2018; 1856():233-243. PubMed ID: 30178255 [TBL] [Abstract][Full Text] [Related]
17. EZH2 in normal hematopoiesis and hematological malignancies. Herviou L; Cavalli G; Cartron G; Klein B; Moreaux J Oncotarget; 2016 Jan; 7(3):2284-96. PubMed ID: 26497210 [TBL] [Abstract][Full Text] [Related]
18. Bisulfite-free epigenomics and genomics of single cells through methylation-sensitive restriction. Niemöller C; Wehrle J; Riba J; Claus R; Renz N; Rhein J; Bleul S; Stosch JM; Duyster J; Plass C; Lutsik P; Lipka DB; Lübbert M; Becker H Commun Biol; 2021 Feb; 4(1):153. PubMed ID: 33526904 [TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferases in hematological malignancies. Hoang NM; Rui L J Genet Genomics; 2020 Jul; 47(7):361-372. PubMed ID: 32994141 [TBL] [Abstract][Full Text] [Related]
20. The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies. Einsele H; Briones J; Ciceri F; García Cadenas I; Falkenburg F; Bolaños N; Heemskerk HMM; Houot R; Hudecek M; Locatelli F; Morgan K; Morris EC; O'Dwyer M; Sierra JG; van den Brink M; van de Loosdrecht AA Hemasphere; 2021 Oct; 5(10):e642. PubMed ID: 34522844 [No Abstract] [Full Text] [Related] [Next] [New Search]